Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 06:22 am Sale |
2024-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
BALYASNY ASSET MANAGEMENT LLC | 0 0.000% |
-3,085,104 (Position Closed) |
Filing History |
| 2024-11-14 06:07 am Purchase |
2024-09-30 | 13G | Leap Therapeutics, Inc. LPTX |
BALYASNY ASSET MANAGEMENT LLC | 3,085,104 8.060% |
3,085,104 (New Position) |
Filing History |
| 2024-10-31 6:29 pm Unchanged |
2024-10-31 | 13D | Leap Therapeutics, Inc. LPTX |
BeiGene Ltd. BGNE |
1,215,306 3.170% |
0 (Unchanged) |
Filing History |
| 2024-10-31 5:40 pm Purchase |
2024-10-31 | 13D | Leap Therapeutics, Inc. LPTX |
BeiGene Ltd. BGNE |
1,215,306 0.000% |
1,215,306 (New Position) |
Filing History |
| 2024-04-25 8:39 pm Purchase |
2024-04-15 | 13G | Leap Therapeutics, Inc. LPTX |
Samsara BioCapital, L.P. | 2,442,352 6.400% |
2,442,352 (New Position) |
Filing History |
| 2024-04-19 4:31 pm Purchase |
2024-04-10 | 13G | Leap Therapeutics, Inc. LPTX |
GILEAD SCIENCES INC GILD |
5,319,148 13.900% |
5,319,148 (New Position) |
Filing History |
| 2024-02-14 4:40 pm Purchase |
2023-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 1,068,497 4.000% |
1,068,497 (New Position) |
Filing History |
| 2023-02-14 2:30 pm Sale |
2022-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 672,650 6.800% |
-175,000 (-20.65%) |
Filing History |
| 2022-02-14 6:55 pm Unchanged |
2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 847,650 9.600% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:05 pm Sale |
2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
HHLR Advisors, Ltd. | 0 0.000% |
-371,624 (Position Closed) |
Filing History |
| 2022-02-11 06:30 am Purchase |
2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
Artal Participations S.a r.l | 400,000 4.500% |
100,000 (+33.33%) |
Filing History |
| 2022-02-10 4:16 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
LILLY ELI & CO LLY |
3,151,605 3.500% |
3,151,605 (New Position) |
Filing History |
| 2021-09-28 6:58 pm Purchase |
2021-09-24 | 13D | Leap Therapeutics, Inc. LPTX |
BeiGene Ltd. BGNE |
1,215,307 13.200% |
254,380 (+26.47%) |
Filing History |
| 2021-02-16 4:25 pm Purchase |
2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
HHLR Advisors, Ltd. | 371,624 6.200% |
371,624 (New Position) |
Filing History |
| 2021-02-16 3:42 pm Purchase |
2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 847,650 14.200% |
175,000 (+26.02%) |
Filing History |
| 2021-02-12 9:06 pm Unchanged |
2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
Artal Participations S.a r.l | 300,000 5.000% |
0 (Unchanged) |
Filing History |
| 2021-02-08 10:27 am Sale |
2021-02-05 | 13G | Leap Therapeutics, Inc. LPTX |
FMR CORP | 60,600 1.005% |
-66,080 (-52.16%) |
Filing History |
| 2020-12-28 4:31 pm Purchase |
2020-12-18 | 13G | Leap Therapeutics, Inc. LPTX |
Artal Participations S.a r.l | 300,000 5.000% |
300,000 (New Position) |
Filing History |